Global Menopausal Hormone Therapy Market Growth (Status and Outlook) 2025-2031

The global Menopausal Hormone Therapy market size is predicted to grow from US$ 27320 million in 2025 to US$ 39480 million in 2031; it is expected to grow at a CAGR of 6.3% from 2025 to 2031.

Menopausal hormone therapy (MHT) is a treatment that uses hormones to relieve the symptoms of menopause. Menopause is a natural process that occurs when a woman's ovaries stop producing estrogen and progesterone. This can cause a variety of symptoms, including hot flashes, night sweats, vaginal dryness, mood swings, and difficulty sleeping.

The menopausal hormone therapy (MHT) market is expected to grow significantly in the coming years, driven by a number of factors, including:

• Rising awareness of the benefits of menopausal hormone therapy
• Changing social norms

The North American region is expected to be the largest market for menopausal hormone therapy, followed by Europe and the Asia Pacific region. The growth of the market in the North American region is being driven by the high prevalence of menopause and the easy availability of menopausal hormone therapy products.

Overall, the menopausal hormone therapy market is expected to grow significantly in the coming years, driven by increasing population of menopausal women, rising awareness of the benefits of menopausal hormone therapy, and changing social norms.

ReportPrime' newest research report, the “Menopausal Hormone Therapy Industry Forecast” looks at past sales and reviews total world Menopausal Hormone Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Menopausal Hormone Therapy sales for 2025 through 2031.

This Insight Report provides a comprehensive analysis of the global Menopausal Hormone Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

This report also analyses the strategies of leading global companies with a focus on Menopausal Hormone Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints.

Segmentation by Type

• Estrogen
• Progesterone

Segmentation by Application

• Hospital
• Clinic
• Others

Market by Region

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

Company Coverage

• Eli Lilly
• Pfizer
• AbbVie
• Novo Nordisk
• Merck KGaA
• Mylan
• Bayer
• Teva
• Novartis
• Abbott
• Roche
• Endo International
• Ipsen
• ANI Pharmaceuticals
• TherapeuticsMD

Key Questions Addressed in this Report